Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu, India.
Protein Structure-Function Research Unit, School of Molecular and Cell Biology, University of the Witwatersrand, Johannesburg, South Africa.
Methods Mol Biol. 2025;2867:185-200. doi: 10.1007/978-1-0716-4196-5_11.
Human immunodeficiency virus (HIV) targets the host immune system causing acquired immunodeficiency syndrome (AIDS). Although significant advancements have been made on investigating HIV and related infections, eradicating the virus from the host immune system is still challenging. Nevertheless, the combination therapies using drugs targeting different stages in the viral life cycle are used for treatment in which HIV protease plays a vital role. Hence, it is essential to understand the structure and function of HIV protease. This review focuses on these aspects from different perspectives such as catalytic mechanism, subtypes and role of flaps in drug binding. Further, we highlight the factors affecting drug binding, evolution of drug resistance, and inhibitors reported in the literature using 3D QSAR studies.
人类免疫缺陷病毒 (HIV) 以宿主免疫系统为靶标,导致获得性免疫缺陷综合征 (AIDS)。尽管在研究 HIV 和相关感染方面取得了重大进展,但要从宿主免疫系统中根除该病毒仍然具有挑战性。然而,使用针对病毒生命周期不同阶段的药物的联合疗法用于治疗,其中 HIV 蛋白酶起着至关重要的作用。因此,了解 HIV 蛋白酶的结构和功能至关重要。本综述从催化机制、亚型和瓣在药物结合中的作用等不同角度关注这些方面。此外,我们还强调了影响药物结合的因素、耐药性的演变以及使用 3D QSAR 研究报告的抑制剂。